$LMND

Peters John Sheldon sold $92K of LMND

Peters John Sheldon (Chief Insurance Officer) sold 1,735 shares of Lemonade, Inc. (LMND) at $53.17 on 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Peters John Sheldon
Published Jun 5, 2026, 9:33 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 9:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LMND
Neutral
medium confidence
Mentioned
$LMND
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LMNDNeutralLow
01

Why it matters

This is a disclosure of ownership change, not a new operating or financial development. The 10b5-1 designation generally lowers the informational content for forecasting near-term fundamentals.

02

Market read

For LMND, the main tradable element is potential short-term sentiment/positioning impact from disclosed insider selling; fundamental read-through is limited by 10b5-1.

03

What to watch

Traders may over-weight insider sales; the key is whether there are concurrent fundamental updates (earnings, guidance, underwriting/claims trends) not present here.

Relevance 6/10Novelty 3/10Timing: SEC Form 4 filed today; sale occurred on 2026-06-03.

Background

The article summarizes a specific SEC Form 4 insider transaction by Lemonade’s Chief Insurance Officer, including trade size, price, and post-transaction holdings.

Company-level read

Ticker impact

$LMNDNeutralMedium confidence
Context

Lemonade COO sold $92.25K of LMND shares via an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low, likely limited to short-term sentiment/flow effects; 10b5-1 reduces signal strength.

Evidence & confidence

The filing provides a specific sale size/date and confirms it was executed under a pre-arranged 10b5-1 plan, which typically dampens interpretive value versus discretionary selling.

Market effects

Minimal—single-company insider transaction with no sector-wide regulatory/product development.

None.

None.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, it may reflect routine liquidity rather than negative expectations.

Key entities

  • Lemonade, Inc.

    Subject of the insider transaction disclosure; shares sold by an officer under a 10b5-1 plan.

  • John Sheldon Peters

    Chief Insurance Officer who executed the open-market sale.

Related articles

$LMNDMed

Lemonade Shares Slide After Results Fail to Meet High Investor Expectations

Lemonade, Inc. (NYSE:LMND) shares fell more than 7% in pre-market trading after the AI-powered insurance company released its second-quarter 2026 results, with investors reacting negatively despite revenue outperforming expectations. The sell-off reflected concerns that the company's outlook failed to justify the high expectations already priced into the stock, following a strong rally earlier in the year.

$LMNDMedAI 8/10

Lemonade Crashes As Customer Growth Miss Spooks Wall Street

Lemonade (LMND) shares fell about 18% in early trading after its Q2 customer growth missed Wall Street expectations. Customers rose 23% to 3.31 million versus a 3.33 million estimate. Revenue increased 79% to $294.4 million, adjusted EBITDA loss narrowed to $18.7 million, and gross loss ratio improved to 60%. Lemonade also announced a CFO transition.

$LMNDMedAI 8/10

Why Lemonade Stock Is Crashing Today

Lemonade (LMND) shares fell about 22% on Wednesday after the company reported Q2 results. Lemonade posted a net loss of $0.56 per share on $294.4 million revenue, matching analyst estimates, with revenue up 79%. It beat sales and gross earned premium targets, but full-year guidance missed on in-force premium, pressuring the stock.

$LMNDMedAI 8/10

Why Lemonade (LMND) Stock Is Nosediving

Lemonade (NYSE: LMND) shares fell 22.7% after the company issued a weaker-than-expected outlook and announced CFO Tim Bixby will step down at year-end, with Nick Stead taking over on Jan. 1, 2027. Revenue rose 79.4% to $294.4 million, but higher marketing costs and near-term expense pressure delayed operating leverage.